The development and evaluation of a provider-focused educational intervention about alcohol use disorder in patients with cirrhosis
Johnson E, Ghosh M, Daniels VJ, Wild TC, Campbell-Scherer D, Mellinger J, Winder GS, Fernandez AC, Kirkwood J, Tandon P. Can Liver J. 2023
Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packs
Duncan K, Scheuermeyer F, Lane D, Ahamad K, Moe J, Dong K, Nolan S, Buxton J, Miles I, Johnson C, Christenson J, Whyte M, Daoust R, Garrod E, Badke K, Kestler A., CJEM. 2023
What impact did the COVID-19 pandemic have on the variability of fentanyl concentrations in the Vancouver, Canada illicit drug supply? An interrupted time-series analysis
Tobias S, Grant CJ, Laing R, Lysyshyn M, Buxton JA, Tupper KW, Wood E, Ti L, BMJ Public Health, 2023.
Modéliser comme vision : explorer l’impact de la réforme de la justice pénale sur la santé des populations atteintes de troubles liés à l’usage de substances
Martin N.K., Beletsky L., Linas B.P., Bayoumi A., Pollack H., Larney S., Justice en santé, 2023
Modéliser comme vision : explorer l’impact de la réforme de la justice pénale sur la santé des populations atteintes de troubles liés à l’usage de substances
Martin N.K., Beletsky L., Linas B.P., Bayoumi A., Pollack H., Larney S., Journal of Urban Health, 2023
Commentary on Brothers et al.: The role of safer environment interventions in addressing injecting-related bacterial and fungal infections
Small W, O’Callaghan S., Addiction. 2023
Evidence base to support using prescribed psychostimulants to treat psychostimulant use disorder is limited
Bahji A, Danilewitz M, George TP, Dhaliwal A, Crockford DN., CMAJ. 2023
Vigilance needed with methamphetamine-associated psychosis
Elefante RJO, Nolan S, Bach PJ., CMAJ. 2023
Navigating Evidence, Challenges, and Caution in the Treatment of Stimulant Use Disorders
Bahji A, Danilewitz M, Crockford D., Brain Sci. 2023
Document d’orientation sur la distribution et l’utilisation de trousses de naloxone à emporter par les intervenants et intervenantes communautaires en cas de surdose au Canada
Ferguson M, Rittenbach K, Leece P, Adams A, Ali F, Elton-Marshall T, Burmeister C, Brothers TD, Medley A, Choisil P, Strike C, Ng J, Lorenzetti DL, Gallant K, Buxton JA; le groupe d’élaboration des documents d’orientation relative à la naloxone, CMAJ, 2023
